Skip to main content

Wainer Andrea F's Form 4 filing

Abbott Laboratories (ABT) · filed Sep 3, 2021

Accession no.
0001415889-21-004250
Filed
Sep 3, 2021
Trade date
Sep 2, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.21M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wainer Andrea FCIK 0001778070Officer (EXECUTIVE VICE PRESIDENT)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 2, 2021Common shares without par valueMOption exerciseAcquired+4,500$47.00+$211,50054,282Direct
Sep 2, 2021Common shares without par valueMOption exerciseAcquired+5,000$38.40+$192,00059,282Direct
Sep 2, 2021Common shares without par valueSSaleDisposed−9,500$127.50−$1,211,25049,782Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 2, 2021Common SharesMOption exerciseDisposed−4,500$0.00$038,226Direct
Sep 2, 2021Common SharesMOption exerciseDisposed−5,000$0.00$030,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

Read the full filing on SEC EDGAR (opens in a new tab)